The multi-provincial influenza drug catalog is officially released, and a number of Chinese patent m
New Media Department Yu Jie, Duan Yuqing March 13, 2023
Recently, influenza occurred across the country . Influenza A (H1N1) is the main type, and H3N2 subtype influenza viruses are co-circulating, causing multiple outbreaks in collective units such as primary and secondary schools, and the number of fever clinics in some medical institutions continues to increase. Compared with the common cold, influenza has a longer incubation period, is more contagious, and has more severe symptoms, which can lead to many serious complications such as pneumonia.
In order to give full play to the advantages of Traditional Chinese Medicine and ensure the medical needs of the masses, the bureaus of Traditional Chinese Medicine in Beijing, Shanghai, Sichuan, Hebei and Shaanxi have recently scientifically formulated the guidance plan for the prevention and treatment of influenza with Traditional Chinese Medicine in the spring of 2023 in their provinces (cities). In the plan, well-known anti-epidemic products of Lunan Pharma, such as Jingfang Granules, Xiaoer Xiaoji Zhike Oral Liquid, Xiaoer Kechuanling Oral Liquid/Granules, and Qingre Jiedu Oral Liquid, were selected into the recommended list.